Katarina Jovanovic

Katarina Jovanovic

Auto-generated profile, based on publicly available information

Katarina Jovanovic

UCL Institute of Ophthalmology, London, UK

Research Focus & Metrics

Academic Career Length

17Years (2010-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2010 in Journal of Molecular Biology
Verified
Journal Article
Closed access
DKDominika Kolodziejczak
Dominika Kolodziejczak
BDBianca Da Costa Dias
Bianca Da Costa Dias
CZChantal Zuber
Chantal Zuber
KJKatarina Jovanovic
Katarina Jovanovic
AOAadilah Omar
Aadilah Omar
SWStefan F.T. Weiss
Stefan F.T. Weiss

1 July 2011 in Prion
Verified
Journal Article
Open access
PDF file
BDBianca Da Costa Dias
Bianca Da Costa Dias
KJKatarina Jovanovic
Katarina Jovanovic
DGDanielle Gonsalves
Danielle Gonsalves
SWStefan F.T. Weiss
Stefan F.T. Weiss
Amyloid β (Aβ) is a major causative agent of Alzheime disease. This neurotoxic peptide is generated as a result of the cleavage of the Amyloid-Precursor-Protein (APP) by the action of beta secretase and gamma secretase. The neurotoxicity was previously thought to be the result of aggregation. However, recent studies suggest that the interaction of Aβ with numerous cell surface receptors such as N-methyl-D-aspartate (NMDA), receptor for advanced glycosylation end products (RAGE), P75 neurotrophin receptor (P75NTR) as well as cell surface proteins such as the cellular prion protein (PrPc) and heparan sulfate proteoglycans (HSPG) strongly enhances Aβ induced apoptosis and thereby contributes to neurotoxicity. This review focuses on the molecular mechanism resulting in Aβ-shedding as well as Aβ-induced apoptotic processes, genetic risk factors for familial Alzheimer disease and interactions of Aβ with cell surface receptors and proteins, with particular emphasis on the cellular prion protein. Furthermore, comparisons are drawn between Alzheimer disease and prion disorders and the role of laminin, an extracellular matrix protein, glycosaminoglycans and the 37 kDa/67 kDa laminin receptor (LRP/LR) have been highlighted with regards to both neurodegenerative diseases.

11 February 2025 in Acta Neuropathologica Communications
Verified
Journal Article
Open access
PDF file
DADimitra Athanasiou
Dimitra Athanasiou
TATess A. V. Afanasyeva
Tess A. V. Afanasyeva
NCNiuzheng Chai
Niuzheng Chai
KZKalliopi Ziaka
Kalliopi Ziaka
KJKatarina Jovanovic
Katarina Jovanovic
MCMichael E. Cheetham
Michael E. Cheetham
Bialleleic pathogenic variants in LCA5 cause one of the most severe forms of Leber congenital amaurosis, an early-onset retinal disease that results in severe visual impairment. Here, we report the use of gene editing to generate isogenic LCA5 knock-out (LCA5 KO) induced pluripotent stem cells (iPSC) and their differentiation to retinal organoids. The molecular and cellular phenotype of the LCA5 KO retinal organoids was studied in detail and compared to isogenic controls as well as patient-derived retinal organoids. The absence of LCA5 was confirmed in retinal organoids by immunohistochemistry and western blotting. There were no major changes in retinal organoid differentiation or ciliation, however, the localisation of CEP290 and IFT88 was significantly altered in LCA5 KO and patient photoreceptor cilia with extension along the axoneme. The LCA5-deficient organoids also had shorter outer segments and rhodopsin was mislocalised to the outer nuclear layer. We also identified transcriptomic and proteomic changes associated with the loss of LCA5. Importantly, treatment with the small molecules eupatilin, fasudil or a combination of both drugs reduced CEP290 and IFT88 accumulation along the cilia. The treatments also improved rhodopsin traffic to the outer segment and reduced mislocalisation of rhodopsin in the outer nuclear layer (ONL). The improvements in cilia-associated protein localisation and traffic were accompanied by significant changes in the transcriptome towards control gene expression levels in many of the differentially expressed genes. In summary, iPSC-derived retinal organoids are a powerful model for investigating the molecular and cellular changes associated with loss of LCA5 function and highlight the therapeutic potential of small molecules to treat retinal ciliopathies.